Swiss company to challenge IGEN and Boehringer
This article was originally published in Clinica
Executive Summary
Laboratoires Serono, a subsidiary of the Swiss pharmaceuticals group, Ares-Serono, has filed suit in the US, alleging that IGEN International's Origen electrochemiluminescence (ECL) technology transgresses its US patent entitled "Method of assay employing a magnetic electrode". The ECL technology is licensed to Boehringer Mannheim and used in Boehringer's Elecsys diagnostic systems.